Skip to main content
. 2021 May 18;13(10):2438. doi: 10.3390/cancers13102438

Figure 1.

Figure 1

Correlation of PGRMC1 and EGFR with survival duration in patients with hepatocellular carcinoma (HCC). (A,B) Kaplan–Meier curves for the relationships of the mRNA levels of (A) PGRMC1 and (B) EGFR with the overall survival duration of patients with hepatocellular carcinoma in two independent cohorts from the GEO database, GSE76427 (left) and GSE20140 (right). (C) EGFR mRNA expression levels in HCC patients with high or low levels of PGRMC1 in the GSE76427 (left) and GSE20140 (right) cohorts.